Barw Barw Medical Journal 2960-1959 2026 05 25 Epithelial-Myoepithelial Carcinoma of Salivary Glands: A Tertiary Center Experience 13 18 10.58742/bmj.v4i1.233 eng Abdulwahid M. Salih Department of Head and Neck Surgery, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq. A.salih@smartglobalholding.co.uk Hiwa O. Abdullah Department of Abdominal Wall Surgery, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq. Hiwa.Abdullah@gmail.com Ari M. Abdullah Department of Pathology, Sulaymaniyah Teaching Hospital, Zanko Street, Sulaymaniyah, Iraq. Ari.abdullah@gmail.com Rebaz O. Mohammed Department of Abdominal Wall Surgery, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq. Rebaz.Mohammed@gmail.com Mariwan L. Fattah Department of Clinical Sciences, College of Medicine, University of Sulaimani, Madam Mitterrand Street, Sulaymaniyah, Iraq. Mariwan.Fattah@gmail.com Imad J. Habibullah Department of Head and Neck Surgery, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq. Imad.Habibullah@gmail.com Sarwat T. San Ahmed Department of Clinical Sciences, College of Medicine, University of Sulaimani, Madam Mitterrand Street, Sulaymaniyah, Iraq. Sarwat.Sanahmed@gmail.com Hawbir A. Muhammed Department of Head and Neck Surgery, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq. Hawbir.Muhammed@gmail.com Rawa S. Ahmed Department of Head and Neck Surgery, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq. Rawa.Ahmed@gmail.com Shamal H. Qadir Department of Head and Neck Surgery, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq. Shamal.Qadir@gmail.com Abdullah A. Qadir Department of Head and Neck Surgery, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq. Abdullah.Qadir@gmail.com Shko H. Hassan Department of Head and Neck Surgery, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq. Shko.Hassan@gmail.com Dindar H. Hama Department of Head and Neck Surgery, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq. Dindar.Hama@gmail.com Las L. Hussain Department of Scientific Affairs, Smart Health Tower, Madam Mitterrand Street, Sulaymaniyah, Iraq . hlasslatif2@gmail.com 2026 03 10 Introduction Epithelial-myoepithelial carcinoma (EMC) is a rare, biphasic malignant tumor affecting the salivary glands. It represents less than 1% of all salivary gland tumors. This study aims to present a single-center experience regarding the diagnosis, management, and prognosis of EMC. Methods This study was conducted between February 2020 and December 2025. Patients with a histopathologically confirmed diagnosis of epithelial-myoepithelial carcinoma were identified. Complete medical records containing demographics, clinical presentation, imaging results, histological features, treatment approaches, and follow-up results were included in the cases. Results Five patients were identified, of which 4 (80%) were females. The mean age was 56 ± 9.38 years. Two patients (40%) presented with painless post-auricular swelling, 1 (20%) with submandibular swelling, and 2 (40%) were incidental findings. Histopathological examination confirmed EMC in all cases. Free margins were achieved in 3 tumors (60%). No recurrence was observed during a mean follow-up of 24 ± 28.92 months. Conclusion Epithelial-myoepithelial carcinoma is a very rare tumor. It requires histopathological evaluation for accurate diagnosis, and complete surgical excision offers favorable short-term outcomes. Further studies are needed to better define its clinical characteristics and outcomes.